Eric Mou, MD
Hematology · Iowa City, IANPI 1184044398
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $4,473 of the $5,315 with a category attached, or 84.2%. Acrotech Biopharma Inc. accounts for 75.2% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $4,542, more than ten times the $135 reported in 2022.
Across 17 payments — averaging $312.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acrotech Biopharma Inc.$4K
- Kyowa Kirin, Inc.$634
- AbbVie$475
- ADC Therapeutics America, Inc.$112
- Bristol Myers Squibb$50
- Beone Medicines USA, Inc.$45
Across 47 payments — averaging $13,999 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$245K
- Beone Medicines USA, Inc.$167K
- Beigene, Ltd.$111K
- Pfizer$88K
- Beone Medicines Ltd.$27K
- Beigene USA, Inc.$19K
- plus $995 from 1 others
What the payments were for
- Consulting fees$4,47384%
- Food & beverage$81915%
- Education$240%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acrotech Biopharma Inc. | 4 | $3,998 |
| Kyowa Kirin, Inc. | 7 | $634 |
| AbbVie | 2 | $475 |
| ADC Therapeutics America, Inc. | 2 | $112 |
| Bristol Myers Squibb | 1 | $50 |
| Beone Medicines USA, Inc. | 1 | $45 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few hematology providers in Iowato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JaypircaPirtobrutinib | 13 | $276,446 |
| VenclextaVenetoclax | 21 | $242,334 |
| CalquenceAcalabrutinib Maleate | 21 | $216,240 |
| Lenalidomide | 16 | $203,232 |
| ValacyclovirValacyclovir Hcl | 22 | $1,083 |
| Acyclovir | 105 | $913 |
| Prochlorperazine Maleate | 34 | $282 |
| Ondansetron Hcl | 27 | $129 |
| Gabapentin | 14 | $122 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 22 | $73 |
| Prednisone | 19 | $33 |
| Allopurinol | 16 | $24 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVenclexta | $475 | $242,33421 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few hematology providers in Iowaon file to place this against a meaningful peer group, so we don't.
Other hematology in Iowa City
- Steven LentzIowa City$193K
- Sabarish AyyappanIowa City$142K
- Michael TomassonIowa City$51K
- Prajwal DhakalIowa City$5K
- Hira ShaikhIowa City$2K
- Sharathkumar BhagavathiIowa City$75
- Kittika PoonsombudlertIowa City$0
- Pedro HsiehIowa City$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.